申请人:Yoshitomi Pharmaceutical Industries, ltd.
公开号:US06015829A1
公开(公告)日:2000-01-18
1-Phenylpyrazole compounds of the formula (1): ##STR1## which is exemplified by 5-amino-1-(3-cyano-4-isobutoxyphenyl)pyrazole-4-carboxylic acid, an optical isomer thereof and a pharmaceutically acceptable salt thereof. These compounds have a xanthine oxidase inhibitory activity and are useful as therapeutic agents for diseases such as hyperuricacidemia and gout.
公式(1)的1-苯基吡唑化合物:##STR1##例如5-氨基-1-(3-氰基-4-异丁氧基苯基)吡唑-4-羧酸及其光学异构体和药学上可接受的盐。这些化合物具有黄嘌呤氧化酶抑制活性,并且可用作治疗高尿酸血症和痛风等疾病的治疗剂。